¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"muscle protein"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • visceral muscle
    ³»Àå±ÙÀ°, ³»Àå±Ù
  • voluntary muscle
    ¼öÀDZÙ, ¸¾´ë·Î±Ù
  • white muscle fiber
    ¹é»ö±Ù(À°)¼¶À¯, ¹é»ö±Ù(À°)¼¼Æ÷
  • yoke muscle
    µ¿Çâ±Ù, ÄÓ·¹±Ù
  • zygomaticus major muscle
    Å«±¤´ë±Ù, ´ë°ü°ñ±Ù
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • smooth muscle relaxant
    ÆòȰ±ÙÀ°Ç®¸²Á¦, ÆòȰ±ÙÀ°ÀÌ¿ÏÁ¦
  • smooth muscle tumor
    ÆòȰ±ÙÁ¾¾ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • accessory respiratory muscle
    º¸Á¶È£Èí±Ù(ÜÍð¾û¼ýåÐÉ)
  • accommodation muscle
    Á¶Àý±Ù(ðàï½ÐÉ).
  • adductor longus muscle
    Àå³»Çâ±Ù, Àå³»Àü±Ù( íþÒ®ï®ÐÉ).
  • adductor pollicis brevis muscle
    ªÀº ¾öÁö¹ú¸²±Ù
  • airway smooth muscle
    ±âµµ ÆòȰ±Ù
  • anconeus muscle
    ÆÈ²ÞÄ¡ ±Ù, ÁÖ±Ù(ÁÖÐÉ).
  • antagonistic muscle
    ±æÇ×±Ù(ÑÏù÷ÐÉ)
  • antagonistic muscle
    ±æÇ×±Ù, ´ëÇ×±Ù
  • anterior auricular muscle
    ÀüÀ̰³±Ù
  • anterior belly of digastric muscle
    µÎÈû»ì±Ù¾ÕÈû»ì
  • anterior papillary muscle
    ¾Õ²ÀÁö±Ù
  • anterior tibial muscle
    Àü¹æ °æ°ñ ±Ù(îñÛ°ÌëÍéÐÉ), Àü °æ°ñ ±Ù(îñÌëÍéÐÉ).
  • antidepolarizing muscle relaxant
    Ç×Å»ºÐ±Ø¼º(ù÷÷­ÝÂпàõ) ±ÙÀ°ÀÌ¿ÏÁ¦.
  • antigravity muscle
    Ç×Á߷±Ù(ù÷ñìÕôÐÉ)
  • antigravity muscle
    Ç×Áß·Â ±Ù(ù÷ñìæ³ÐÉ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 19
FDI first dorsal interosseous [muscle]; International Dental Federation [Federation Dentaire Internation...
gastroc gastrocnemius [muscle]
IMT indomethacin; induced muscular tension; inspiratory muscle training
IR drop of voltage across a resistor produced by a current; ileal resection; immune response; immunizat...
ISM information sources map [of UMLS]; International Society of Microbiologists; intersegmental muscle
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 19
PFM pelvic floor muscle
PCA posterior cricoarytenoid muscle
PASMC pulmonary arterial smooth muscle cell
RASM rat aortic smooth muscle
SKM skeletal muscle
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • tonic muscle
    ±äÀå±Ù
  • total elasticity of muscle
    ±ÙÀ° ÃÑ Åº¼º
  • triceps brachii muscle
    »ó¿Ï »ïµÎ±Ù, »óµÎ¹Ú±Ù
    »ó¿Ï µÚÂÊ¿¡ ÀÖ´Â ±â´Ù¶õ ±ÙÀ°. »ïµÎ¹Ú±ÙÀ̶ó°íµµ ÇÑ´Ù. ½ÃÀ۵Ǵ ºÎºÐÀº ¼ÂÀ¸·Î ³ª´©¾îÁ® ÀÖ°í, ÀåµÎ´Â °ß°©°ñÀÇ ¿ÜÃø¿¡¼­, ³»ÃøµÎ¿Í ¿ÜÃøµÎ´Â »ó¿Ï°ñü Èĸ鿡¼­ ½ÃÀ۵Ǿî ÇÕÃÄÁ® ±Ùº¹À» ÀÌ·é´Ù. Á¤Áö°ÇÀº ô°ñÀÇ ³¡ Áֵο¡ ºÎÂøÇÑ´Ù. ÁÖ°üÀýÀ» Æì´Â ÀÏÀ» Çϸç, ¿ä°ñ ½Å°æÀÇ Áö¹è¸¦ ¹Þ´Â´Ù.
  • unipennate muscle
    ¹Ý±ê ¸ð¾ç±Ù, ¹Ý¿ì»ó±Ù
  • upper trapezius muscle
    »ó½Â¸ð±Ù
  • vascular smooth muscle
    Ç÷°ü ÆòȰ±Ù
  • visceral muscle
    ³»Àå±Ù
    ¼ÒÈ­±â, ½ÉÀå, ±× ¹ÛÀÇ ³»ÀåÀÇ ºÒ¼öÀÇ ¿îµ¿¿¡ °ü¿©ÇÏ´Â ±ÙÀ°. °ñ°Ý±Ù¿¡ ´ëÀÀµÇ´Â ¸»ÀÌ´Ù. °ñ°Ý±ÙÀÌ ±¸°£
  • white muscle
    ¹é»ö ±Ù
    ôÃßµ¿¹°ÀÇ °¡·Î¹«´Ì±Ù Áß ¹Ì¿À±Û·ÎºóÀÇ ¾çÀÌ Àû±â ¶§¹®¿¡ ¹«»ö ¶Ç´Â ¾ÆÁÖ ¿¬ÇÑ Àû»öÀ» º¸ÀÌ´Â °Í. Àû»ö ±Ù¿¡ ´ëÀÀµÇ´Â ¸»ÀÌ´Ù. ÀϹÝÀûÀ¸·Î ¹°°í±â »ì¿¡ ´ëÇÏ¿© »ç¿ëÇϸç, Èò »ì, ºÓÀº »ìÀÇ ¹°°í±â¶ó ÇÑ´Ù. Àú»ý¾î¿¡ ¹é»ö ±ÙÀÇ ¹°°í±â°¡ ¸¹´Ù.
  • white muscle fiber
    ¹é»ö ±Ù ¼¶À¯
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
protein-tyrosine-phosphatase <enzyme> An enzyme group that specifically dephosphorylates phosphotyrosyl residues in selected proteins. Together with protein-tyrosine kinase, it regulates tyrosine phosphorylation and dephosphorylation in cellular signal transduction and may play a role in cell growth control and carcinogenesis.
Chemical name: Protein-tyrosine-phosphate phosphohydrolase
Registry number: EC 3.1.3.48
(12 Dec 1998)
protein Zero <protein> The major glycoprotein of peripheral nerve myelin, an integral transmembrane protein, synthesised by Schwann cells (Mw = 28, 500).
(18 Nov 1997)
proteolipid protein <protein> Highly conserved membrane protein (30 kD) in myelin. Cellular function obscure but mutations lethal for example jimpy mouse and Pelizaeus Merzbacher disease of man.
(18 Nov 1997)
proto-oncogene protein p21(ras) Cellular protein encoded by the c-ras genes. The protein has GTPase activity and is involved in transmembrane signal transduction as a guanine nucleotide binding protein. Elevated levels of p21 c-ras have been associated with neoplasia.
(12 Dec 1998)
proto-oncogene protein pp60(c-src) <enzyme> Membrane-associated tyrosine-specific kinase encoded by the c-src genes. It has an important role in cellular growth control. Truncation of carboxy-terminal residues in pp60(c-src) leads to pp60(v-src) which has the ability to transform cells. This kinase pp60 c-src should not be confused with csk, also known as c-src kinase.
Registry number: EC 2.7.1.-
(12 Dec 1998)
heterologous protein A protein that differs from any protein normally found in the organism in question.
Synonym: heterologous protein.
(05 Mar 2000)
prp 27-30 protein Protease-resistant core of prpsc, the abnormal isoform of prion proteins (prions). Prp 27-30 is produced by limited proteolysis of the n-terminus of prpsc.
(12 Dec 1998)
high-mobility group protein <protein> An HMG protein is one of a group of various different proteins which are somehow involved with chromatin, but which are not histones and whose exact function is not known.
(09 Oct 1997)
HIV core protein p24 A major core protein of the human immunodeficiency virus encoded by the HIV gag gene. HIV-seropositive individuals mount a significant immune response to p24 and thus detection of antibodies to p24 is one basis for determining HIV infection by elisa and western blot assays. The protein is also being investigated as a potential HIV immunogen in vaccines.
(12 Dec 1998)
HIV envelope protein gp120 External envelope protein of the human immunodeficiency virus which is encoded by the HIV env gene. It has a molecular weight of 120,000 kD and contains numerous glycosylation sites. Gp120 binds to cells expressing CD4 cell-surface antigens, most notably t4-lymphocytes and monocytes/macrophages. Gp120 has been shown to interfere with the normal function of CD4 and is at least partly responsible for the cytopathic effect of HIV.
(12 Dec 1998)
HIV envelope protein gp160 An envelope protein of the human immunodeficiency virus that is encoded by the HIV env gene. It has a molecular weight of 160,000 kD and contains numerous glycosylation sites. It serves as a precursor for both the HIV envelope protein gp120 and the HIV envelope protein gp41.
(12 Dec 1998)
HIV envelope protein gp41 Transmembrane envelope protein of the human immunodeficiency virus which is encoded by the HIV env gene. It has a molecular weight of 41,000 and is glycosylated. The n-terminal part of gp41 is thought to be involved in cell fusion with the CD4 antigens of t4 lymphocytes, leading to syncytial formation. Gp41 is one of the most common HIV antigens detected by immunoblotting.
(12 Dec 1998)
PTC protein Formed by the reaction of phenylisothiocyanate with a terminal alpha-amino group of a peptide or protein
See: phenylisothiocyanate, phenylthiohydantoin.
Synonym: PhNCS protein, PTC protein.
(05 Mar 2000)
hn protein Glycoprotein from sendai, para-influenza, newcastle disease, and other viruses that participates in binding the virus to cell-surface receptors. The hn protein possesses both haemagglutinin and neuraminidase activity.
(12 Dec 1998)
secretory protein <protein> In eukaryotes, proteins synthesised on rough endoplasmic reticulum and destined for export. Nearly all proteins secreted from cells are glycosylated (in the Golgi apparatus, although there are exceptions (albumin). In prokaryotes, secreted proteins may be synthesised on ribosomes associated with the plasma membrane or exported post translation.
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 19
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 19
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 19
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 19
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 19
ÅëÇÕ°Ë»ö ¿Ï·á